MOSSENTA, MONICA

MOSSENTA, MONICA  

Dipartimento di Scienze della Vita  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autori File
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 1-gen-2023 Busato, DavideCapolla, SaraDurigutto, PaoloMossenta, MonicaBozzer, SaraSblattero, DanieleMacor, PaoloToffoli, Giuseppe +
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients 1-gen-2021 Bedon L.Mossenta M.Busato D.Toffoli G. +
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies 1-gen-2020 Monica MossentaDavide BusatoGiuseppe Toffoli +
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma 1-gen-2025 Mossenta MCapolla SDAVIDE BUSATODurigutto PMangogna ASblattero DMacor PToffoli G +
New insight into therapies targeting angiogenesis in hepatocellular carcinoma 1-gen-2019 Monica MossentaDavide BusatoFederica Di CintioGiuseppe Toffoli +
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies 1-gen-2022 Mossenta M.Busato D.Toffoli G. +
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma 1-gen-2022 Busato, DavideMossenta, MonicaMacor, PaoloToffoli, Giuseppe +